These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 22108639

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Transdermal delivery of naloxone: skin permeation, pharmacokinetic, irritancy and stability studies.
    Panchagnula R, Bokalial R, Sharma P, Khandavilli S.
    Int J Pharm; 2005 Apr 11; 293(1-2):213-23. PubMed ID: 15778059
    [Abstract] [Full Text] [Related]

  • 4. Is transdermal iontophoretic delivery of naloxone sufficient for the management of intoxication in opioid-overdosed patients?
    Sanaei-Zadeh H.
    Int J Pharm; 2012 May 30; 428(1-2):187. PubMed ID: 22426321
    [No Abstract] [Full Text] [Related]

  • 5. In vitro and in vivo evaluation of a hydrogel-based prototype transdermal patch system of alfuzosin hydrochloride.
    Nair AB, Vaka SR, Gupta S, Repka MA, Murthy SN.
    Pharm Dev Technol; 2012 May 30; 17(2):158-63. PubMed ID: 20958130
    [Abstract] [Full Text] [Related]

  • 6. Transdermal iontophoretic delivery of tacrine hydrochloride: Correlation between in vitro permeation and in vivo performance in rats.
    Patel N, Jain S, Lin S.
    Int J Pharm; 2016 Nov 20; 513(1-2):393-403. PubMed ID: 27633278
    [Abstract] [Full Text] [Related]

  • 7. Using transdermal iontophoresis to increase granisetron delivery across skin in vitro and in vivo: effect of experimental conditions and a comparison with other enhancement strategies.
    Cázares-Delgadillo J, Ganem-Rondero A, Quintanar-Guerrero D, López-Castellano AC, Merino V, Kalia YN.
    Eur J Pharm Sci; 2010 Mar 18; 39(5):387-93. PubMed ID: 20096354
    [Abstract] [Full Text] [Related]

  • 8. Transdermal iontophoresis of hydromorphone across hairless rat skin in vitro.
    Kumar MG, Lin S.
    Pharm Dev Technol; 2009 Mar 18; 14(1):106-15. PubMed ID: 18825546
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Enhancement of skin permeation of bufalin by limonene via reservoir type transdermal patch: formulation design and biopharmaceutical evaluation.
    Yang Z, Teng Y, Wang H, Hou H.
    Int J Pharm; 2013 Apr 15; 447(1-2):231-40. PubMed ID: 23467076
    [Abstract] [Full Text] [Related]

  • 13. Transdermal iontophoretic delivery of terbinafine hydrochloride: quantitation of drug levels in stratum corneum and underlying skin.
    Sachdeva V, Siddoju S, Yu YY, Kim HD, Friden PM, Banga AK.
    Int J Pharm; 2010 Mar 30; 388(1-2):24-31. PubMed ID: 20025950
    [Abstract] [Full Text] [Related]

  • 14. Non-invasive iontophoretic delivery of enzymatically active ribonuclease A (13.6 kDa) across intact porcine and human skins.
    Dubey S, Kalia YN.
    J Control Release; 2010 Aug 03; 145(3):203-9. PubMed ID: 20423719
    [Abstract] [Full Text] [Related]

  • 15. Transdermal delivery of naloxone: ex vivo permeation studies.
    Jaiswal J, Poduri R, Panchagnula R.
    Int J Pharm; 1999 Mar 01; 179(1):129-34. PubMed ID: 10053209
    [Abstract] [Full Text] [Related]

  • 16. Transdermal iontophoretic delivery of selegiline hydrochloride, in vitro.
    Kolli CS, Chadha G, Xiao J, Parsons DL, Babu RJ.
    J Drug Target; 2010 Nov 01; 18(9):657-64. PubMed ID: 20038213
    [Abstract] [Full Text] [Related]

  • 17. Iontophoretic transdermal delivery of glycyrrhizin: effects of pH, drug concentration, co-ions, current intensity, and chemical enhancers.
    Yamamoto R, Takasuga S, Kominami K, Sutoh C, Kinoshita M, Kanamura K, Takayama K.
    Chem Pharm Bull (Tokyo); 2013 Nov 01; 61(12):1275-81. PubMed ID: 24292789
    [Abstract] [Full Text] [Related]

  • 18. Transdermal iontophoresis of dexamethasone sodium phosphate in vitro and in vivo: effect of experimental parameters and skin type on drug stability and transport kinetics.
    Cázares-Delgadillo J, Balaguer-Fernández C, Calatayud-Pascual A, Ganem-Rondero A, Quintanar-Guerrero D, López-Castellano AC, Merino V, Kalia YN.
    Eur J Pharm Biopharm; 2010 Jun 01; 75(2):173-8. PubMed ID: 20332024
    [Abstract] [Full Text] [Related]

  • 19. Controlled iontophoretic delivery of pramipexole: electrotransport kinetics in vitro and in vivo.
    Kalaria DR, Patel P, Merino V, Patravale VB, Kalia YN.
    Eur J Pharm Biopharm; 2014 Sep 01; 88(1):56-63. PubMed ID: 24525072
    [Abstract] [Full Text] [Related]

  • 20. Controlled iontophoretic transport of huperzine A across skin in vitro and in vivo: effect of delivery conditions and comparison of pharmacokinetic models.
    Kalaria DR, Patel P, Merino V, Patravale VB, Kalia YN.
    Mol Pharm; 2013 Nov 04; 10(11):4322-9. PubMed ID: 24028565
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.